glp-1 and brain health Role of glucagon-like peptide-1 receptor agonists in Alzheimer's disease Parkinson's disease | Journal of Biomedical Science GLP-1 and the Degenerating Brain:

GLP-1 receptor agonists like Ozempic and Victoza were originally developed to treat type 2 diabetes, but their weight loss effects were quickly discovered

The mechanism involves the suppression of pro-inflammatory chemokine (C-C motif) ligand 20 (CCL20), which is of significant importance in the Th17 immune response, as well as IL-33, which is a key cytokine associated with Th2 immune responses [224]

Individual variation is the rule, not the exception

How we coach hunger and satiety in the first 30 days, the pause that protects your plan One of the most helpful skills in month one is a short pause before and after meals

Gupta AK, Joshi MB, Philippova M, Erne P, Hasler P, Hahn S, et al

This article is part of the Medical Insights vertical on Op-Med, which features study breakdowns, resources, and insights from Doximity members on popular topics in medicine